Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 801 to 825 of about 6087

Previous 25

Website Changes

11/18/2021

Presentation of XCELSIOR Observational Protocol for Real World Data Research

11/15/2021

2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma

11/15/2021

Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting

11/13/2021

Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States

11/13/2021

xCures presents the results of their oncology platform at the 2021 SNO Annual Meeting

11/13/2021

Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

11/11/2021

PNOC Study in Childhood Brain Cancer Enrolls First Patient

11/11/2021

Temporary opening of the blood-brain barrier with the nitrone compound OKN-007

11/11/2021

Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021

11/05/2021

Japan offers new treatment option for brain cancer

11/05/2021

Jaime Leandro Foundation treats first cancer patient

11/04/2021

Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma

11/04/2021

A new treatment for brain tumors available in France (Onc-201)

11/01/2021

External Controls to Improve on Glioblastoma Clinical Trials

10/29/2021

Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study

10/28/2021

xCures launched xUTILITY Real-World Oncology Datasets

10/27/2021

A combined treatment regimen of MGMT-modified ?d T cells and temozolomide chemotherapy is effective against primary high grade gliomas

10/26/2021

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

10/20/2021

NY hospital recruiting cancer patients for groundbreaking treatment loopcayman 20 hrs ago

10/20/2021

PLUS THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR 186RNL FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

10/16/2021

Systemic coagulation is activated in patients with meningioma and glioblastoma

10/07/2021

ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)

10/04/2021

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial

10/04/2021

Sharing your GBM Experience Helps Others

09/30/2021

Oblato Announces that it has received a Positive Response from the FDA for the use of OKN-007 for patients with high-grade gliomas in an Expanded Access Program

Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!